BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23322716)

  • 1. Neurofibromatosis type 2 in the elderly population: clinical and molecular features.
    Goutagny S; Bah AB; Parfait B; Sterkers O; Kalamarides M
    Am J Med Genet A; 2013 Apr; 161A(4):667-70. PubMed ID: 23322716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
    Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
    J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene.
    Sestini R; Vivarelli R; Balestri P; Ammannati F; Montali E; Papi L
    Hum Genet; 2000 Oct; 107(4):366-71. PubMed ID: 11129337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 2 (NF2): a clinical and molecular review.
    Evans DG
    Orphanet J Rare Dis; 2009 Jun; 4():16. PubMed ID: 19545378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 2.
    Evans DG
    Handb Clin Neurol; 2015; 132():87-96. PubMed ID: 26564072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
    Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
    Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral vestibular schwannomas in older patients: NF2 or chance?
    Evans DG; Freeman S; Gokhale C; Wallace A; Lloyd SK; Axon P; Ward CL; Rutherford S; King A; Huson SM; Ramsden RT;
    J Med Genet; 2015 Jun; 52(6):422-4. PubMed ID: 25725045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
    Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
    J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
    Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
    J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.
    Ruggieri M; Praticò AD; Evans DG
    Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.
    Kluwe L; Mautner V; Heinrich B; Dezube R; Jacoby LB; Friedrich RE; MacCollin M
    J Med Genet; 2003 Feb; 40(2):109-14. PubMed ID: 12566519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in an extended pedigree.
    Sainio M; Strachan T; Blomstedt G; Salonen O; Setälä K; Palotie A; Palo J; Pyykkö I; Peltonen L; Jääskeläinen J
    Neurology; 1995 Jul; 45(7):1314-22. PubMed ID: 7617190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of neurofibromatosis type 2 with onset before the age of 1 year.
    Ruggieri M; Gabriele AL; Polizzi A; Salpietro V; Nicita F; Pavone P; Platania N; Milone P; Distefano A; Privitera G; Belfiore G; Granata F; Caltabiano R; Albanese V; Pavone L; Quattrone A
    Neurogenetics; 2013 May; 14(2):89-98. PubMed ID: 23377185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.
    Kluwe L; Friedrich RE; Hagel C; Lindenau M; Mautner VF
    J Invest Dermatol; 2000 May; 114(5):1017-21. PubMed ID: 10771486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
    Sainz J; Huynh DP; Figueroa K; Ragge NK; Baser ME; Pulst SM
    Hum Mol Genet; 1994 Jun; 3(6):885-91. PubMed ID: 7951231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.